After other firms’ setbacks, Prilenia readies for readout on Huntington’s drug that improves daily function

Author(s)

Kenneth P. Serbin PhD, University of San DiegoFollow

Document Type

Blog Post

Publication Date

8-30-2022

Digital USD Citation

Serbin, Kenneth P. PhD, "After other firms’ setbacks, Prilenia readies for readout on Huntington’s drug that improves daily function" (2022). At Risk for Huntington's Disease. 335.
https://digital.sandiego.edu/huntingtons/335